In a community update to the HD community by the sponsor, an increase in serum neurofilament light chain (NfL) and neurological symptoms and nerve conduction studies consistent with peripheral neuropathy were reported in branaplam-treated individuals.4 The gene discussed is NEFL; the disease is peripheral neuropathy.